These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15914230)

  • 21. Virology. Weapons of mutational destruction.
    KewalRamani VN; Coffin JM
    Science; 2003 Aug; 301(5635):923-5. PubMed ID: 12920286
    [No Abstract]   [Full Text] [Related]  

  • 22. Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.
    Luo K; Wang T; Liu B; Tian C; Xiao Z; Kappes J; Yu XF
    J Virol; 2007 Jul; 81(13):7238-48. PubMed ID: 17428847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.
    Chiu YL; Soros VB; Kreisberg JF; Stopak K; Yonemoto W; Greene WC
    Nature; 2005 May; 435(7038):108-14. PubMed ID: 15829920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA deamination mediates innate immunity to retroviral infection.
    Harris RS; Bishop KN; Sheehy AM; Craig HM; Petersen-Mahrt SK; Watt IN; Neuberger MS; Malim MH
    Cell; 2003 Jun; 113(6):803-9. PubMed ID: 12809610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.
    Sandrin V; Muriaux D; Darlix JL; Cosset FL
    J Virol; 2004 Jul; 78(13):7153-64. PubMed ID: 15194792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of murine leukemia virus pol with virions, independent of Gag-Pol expression.
    Buchschacher GL; Yu L; Murai F; Friedmann T; Miyanohara A
    J Virol; 1999 Nov; 73(11):9632-7. PubMed ID: 10516075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Murine leukemia virus resists producer cell APOBEC3A by its Glycosylated Gag but not target cell APOBEC3A.
    Jaguva Vasudevan AA; Balakrishnan K; Franken A; Krikoni A; Häussinger D; Luedde T; Münk C
    Virology; 2021 May; 557():1-14. PubMed ID: 33581610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases.
    Dutko JA; Schäfer A; Kenny AE; Cullen BR; Curcio MJ
    Curr Biol; 2005 Apr; 15(7):661-6. PubMed ID: 15823539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase.
    Suspène R; Sommer P; Henry M; Ferris S; Guétard D; Pochet S; Chester A; Navaratnam N; Wain-Hobson S; Vartanian JP
    Nucleic Acids Res; 2004; 32(8):2421-9. PubMed ID: 15121899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple Gag domains contribute to selective recruitment of murine leukemia virus (MLV) Env to MLV virions.
    Gregory DA; Lyddon TD; Johnson MC
    J Virol; 2013 Feb; 87(3):1518-27. PubMed ID: 23152533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.
    Marin M; Rose KM; Kozak SL; Kabat D
    Nat Med; 2003 Nov; 9(11):1398-403. PubMed ID: 14528301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells.
    Chen K; Huang J; Zhang C; Huang S; Nunnari G; Wang FX; Tong X; Gao L; Nikisher K; Zhang H
    J Virol; 2006 Aug; 80(15):7645-57. PubMed ID: 16840343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional domains of APOBEC3G required for antiviral activity.
    Li J; Potash MJ; Volsky DJ
    J Cell Biochem; 2004 Jun; 92(3):560-72. PubMed ID: 15156567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 Vif and APOBEC3G: multiple roads to one goal.
    Goncalves J; Santa-Marta M
    Retrovirology; 2004 Sep; 1():28. PubMed ID: 15383144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Species-specific restriction of apobec3-mediated hypermutation.
    Browne EP; Littman DR
    J Virol; 2008 Feb; 82(3):1305-13. PubMed ID: 18032489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.
    Sheehy AM; Gaddis NC; Malim MH
    Nat Med; 2003 Nov; 9(11):1404-7. PubMed ID: 14528300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging.
    Zhao W; Akkawi C; Mougel M; Ross SR
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid evolution of primate antiviral enzyme APOBEC3G.
    Zhang J; Webb DM
    Hum Mol Genet; 2004 Aug; 13(16):1785-91. PubMed ID: 15198990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses.
    Esnault C; Heidmann O; Delebecque F; Dewannieux M; Ribet D; Hance AJ; Heidmann T; Schwartz O
    Nature; 2005 Jan; 433(7024):430-3. PubMed ID: 15674295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The incorporation of APOBEC3 proteins into murine leukemia viruses.
    Zhang L; Li X; Ma J; Yu L; Jiang J; Cen S
    Virology; 2008 Aug; 378(1):69-78. PubMed ID: 18572219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.